These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 15688393)

  • 1. Characterization of a rat model with site-specific bone metastasis induced by MDA-MB-231 breast cancer cells and its application to the effects of an antibody against bone sialoprotein.
    Bäuerle T; Adwan H; Kiessling F; Hilbig H; Armbruster FP; Berger MR
    Int J Cancer; 2005 Jun; 115(2):177-86. PubMed ID: 15688393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of bone metastasis induced by MDA-MB-231 breast cancer cells with an antibody against bone sialoprotein.
    Bäuerle T; Peterschmitt J; Hilbig H; Kiessling F; Armbruster FP; Berger MR
    Int J Oncol; 2006 Mar; 28(3):573-83. PubMed ID: 16465361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of zoledronic acid and an antibody against bone sialoprotein II on MDA-MB-231(GFP) breast cancer cells in vitro and on osteolytic lesions induced in vivo by this cell line in nude rats.
    Peterschmitt J; Bäuerle T; Berger MR
    Clin Exp Metastasis; 2007; 24(6):449-59. PubMed ID: 17636409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rat monoclonal antibodies against bone sialoprotein II inhibit tumor growth and osteolytic lesions in nude rats induced by MDA-MB-231 breast cancer cells.
    Zepp M; Armbruster FP; Berger MR
    Int J Clin Pharmacol Ther; 2010 Jul; 48(7):462-4. PubMed ID: 20557845
    [No Abstract]   [Full Text] [Related]  

  • 5. Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis.
    Guise TA; Yin JJ; Taylor SD; Kumagai Y; Dallas M; Boyce BF; Yoneda T; Mundy GR
    J Clin Invest; 1996 Oct; 98(7):1544-9. PubMed ID: 8833902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early detection of bone metastases in a murine model using fluorescent human breast cancer cells: application to the use of the bisphosphonate zoledronic acid in the treatment of osteolytic lesions.
    Peyruchaud O; Winding B; Pécheur I; Serre CM; Delmas P; Clézardin P
    J Bone Miner Res; 2001 Nov; 16(11):2027-34. PubMed ID: 11697798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Site-specific human breast cancer (MDA-MB-231) metastases in nude rats: model characterisation and in vivo effects of ibandronate on tumour growth.
    Neudert M; Fischer C; Krempien B; Bauss F; Seibel MJ
    Int J Cancer; 2003 Nov; 107(3):468-77. PubMed ID: 14506749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sustained delivery and efficacy of polymeric nanoparticles containing osteopontin and bone sialoprotein antisenses in rats with breast cancer bone metastasis.
    Elazar V; Adwan H; Bäuerle T; Rohekar K; Golomb G; Berger MR
    Int J Cancer; 2010 Apr; 126(7):1749-60. PubMed ID: 19739076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Over-expression of bone sialoprotein enhances bone metastasis of human breast cancer cells in a mouse model.
    Zhang JH; Tang J; Wang J; Ma W; Zheng W; Yoneda T; Chen J
    Int J Oncol; 2003 Oct; 23(4):1043-8. PubMed ID: 12963984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. E-cadherin expression in human breast cancer cells suppresses the development of osteolytic bone metastases in an experimental metastasis model.
    Mbalaviele G; Dunstan CR; Sasaki A; Williams PJ; Mundy GR; Yoneda T
    Cancer Res; 1996 Sep; 56(17):4063-70. PubMed ID: 8752180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cilengitide inhibits metastatic bone colonization in a nude rat model.
    Bretschi M; Merz M; Komljenovic D; Berger MR; Semmler W; Bäuerle T
    Oncol Rep; 2011 Oct; 26(4):843-51. PubMed ID: 21725616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transfection of MDA-MB-231 human breast carcinoma cells with bone sialoprotein (BSP) stimulates migration and invasion in vitro and growth of primary and secondary tumors in nude mice.
    Sharp JA; Waltham M; Williams ED; Henderson MA; Thompson EW
    Clin Exp Metastasis; 2004; 21(1):19-29. PubMed ID: 15065599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-modal imaging of angiogenesis in a nude rat model of breast cancer bone metastasis using magnetic resonance imaging, volumetric computed tomography and ultrasound.
    Bäuerle T; Komljenovic D; Berger MR; Semmler W
    J Vis Exp; 2012 Aug; (66):e4178. PubMed ID: 22929330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging anti-angiogenic treatment response with DCE-VCT, DCE-MRI and DWI in an animal model of breast cancer bone metastasis.
    Bäuerle T; Bartling S; Berger M; Schmitt-Gräff A; Hilbig H; Kauczor HU; Delorme S; Kiessling F
    Eur J Radiol; 2010 Feb; 73(2):280-7. PubMed ID: 19070445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone sialoprotein promotes bone metastasis of a non-bone-seeking clone of human breast cancer cells.
    Zhang JH; Wang J; Tang J; Barnett B; Dickson J; Hahsimoto N; Williams P; Ma W; Zheng W; Yoneda T; Pageau S; Chen J
    Anticancer Res; 2004; 24(3a):1361-8. PubMed ID: 15274296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrin alpha(v)beta3 expression confers on tumor cells a greater propensity to metastasize to bone.
    Pécheur I; Peyruchaud O; Serre CM; Guglielmi J; Voland C; Bourre F; Margue C; Cohen-Solal M; Buffet A; Kieffer N; Clézardin P
    FASEB J; 2002 Aug; 16(10):1266-8. PubMed ID: 12153995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone sialoprotein mediates the tumor cell-targeted prometastatic activity of transforming growth factor beta in a mouse model of breast cancer.
    Nam JS; Suchar AM; Kang MJ; Stuelten CH; Tang B; Michalowska AM; Fisher LW; Fedarko NS; Jain A; Pinkas J; Lonning S; Wakefield LM
    Cancer Res; 2006 Jun; 66(12):6327-35. PubMed ID: 16778210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silencing of skeletal metastasis-associated genes impairs migration of breast cancer cells and reduces osteolytic bone lesions.
    Reufsteck C; Lifshitz-Shovali R; Zepp M; Bäuerle T; Kübler D; Golomb G; Berger MR
    Clin Exp Metastasis; 2012 Jun; 29(5):441-56. PubMed ID: 22407340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustained conditional knockdown reveals intracellular bone sialoprotein as essential for breast cancer skeletal metastasis.
    Kovacheva M; Zepp M; Berger SM; Berger MR
    Oncotarget; 2014 Jul; 5(14):5510-22. PubMed ID: 24980816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bisphosphonate risedronate reduces metastatic human breast cancer burden in bone in nude mice.
    Sasaki A; Boyce BF; Story B; Wright KR; Chapman M; Boyce R; Mundy GR; Yoneda T
    Cancer Res; 1995 Aug; 55(16):3551-7. PubMed ID: 7627963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.